Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
NCT07067346 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2025-07-29
Summary
Radiopharmaceutical in Relapsed/Refractory Neuroblastoma
Conditions
Interventions
- DRUG
-
IR-101
IR-101 Dose Escalation
Sponsors & Collaborators
-
Sichuan University
lead OTHER
Principal Investigators
-
Rong Tian, MD · West China Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-18
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- China
Study Locations
More Related Trials
-
Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab
NCT07100704 ·Status: RECRUITING ·Phase: PHASE2
-
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT06974812 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
NCT01534585 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06198426 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
NCT07059832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors
NCT05636215 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
NCT07064746 ·Status: RECRUITING
-
A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors
NCT06154343 ·Status: RECRUITING ·Phase: PHASE1
-
De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
NCT06572514 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
NCT00700440 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy
NCT06414577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
NCT06031597 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Microtransplantation for Advanced and Relapsed Solid Tumors
NCT04937842 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma
NCT05460767 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.
NCT03545971 ·Status: COMPLETED ·Phase: PHASE1
-
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
NCT05649163 ·Status: UNKNOWN
-
Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
NCT06611657 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal Carcinoma
NCT04533620 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
NCT04421352 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT05923008 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT
NCT01817023 ·Status: UNKNOWN ·Phase: PHASE3
-
De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT04158518 ·Status: UNKNOWN ·Phase: NA
-
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
NCT07327632 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
NCT05315167 ·Status: RECRUITING ·Phase: PHASE1/PHASE2